Conditions: Advanced Breast Cancer
Keywords: Advanced Breast Cancer
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 75
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine whether AZD2171 can effectively improve time to tumour progression when added to fulvestrant in patients with advanced hormone sensitive breast cancer who progressed on prior hormonal therapy.

Detailed description:

Arms:
arm 1: Fulvestrant Monotherapy arm 2: AZD2171 + Fulvestrant

Interventions: intervention 1: AZD2171 intervention 2: Fulvestrant
Intervention descriptions: intervention 1: Oral tablet intervention 2: intramuscular injection

Protocol document: